Atlas Trials

Zhiyong Yu

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Zhiyong Yu

RecordFirmDate
Pyrotinib and Vinorelbine Tartrate Capsules With or Without Inetetamab for First Line Treatment in Patients With Trastuzumab-resistant HER2-positive Advanced Breast Cancer (NCT04963595)Zhiyong Yu2021-08-01
Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy (NCT03703427)Zhiyong Yu2018-11-01
Potential of Circulating Tumor DNA to Assess the Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer Patients (NCT03688035)Zhiyong Yu2018-09-20
The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy (NCT03423849)Zhiyong Yu2018-02-08
Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer (NCT03373708)Zhiyong Yu2017-12-20
Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy (NCT03349177)Zhiyong Yu2017-11-27

Track Zhiyong Yu automatically

Every clearance here is in the API, with alerts when new ones post.